Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization
Authors:
- Maarten L. van RoosmalenMRMaarten L. van Roosmalen
- Jolanda NeefJNJolanda Neef
- Rolf KanningaRKRolf Kanninga
- Eduard PostEPEduard Post
- Mariëlle van DeemterMDMariëlle van Deemter
- Heidi MetselaarHMHeidi Metselaar
- Saskia van SelmSSSaskia van Selm
- George T. RobillardGRGeorge T. Robillard
- Kees J. LeenhoutsKLKees J. Leenhouts
- Peter W.M. HermansPHPeter W.M. Hermans
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Immunoglobulin‐A antibodies in Upper Airway Secretions may Inhibit Intranasal Influenza Virus Replication in Mice but not Protect Against Clinical IllnessScandinavian Journal of Immunology, 2005
- Mucosal immunity and vaccinesNature Medicine, 2005
- Mucosal adjuvantsVaccine, 2005
- Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisationVaccine, 2005
- A novel intranasal Protollin™-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in miceVaccine, 2005
- An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococciJournal of Medical Microbiology, 2004
- Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccinesVaccine, 2003
- Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV EnvBlood, 2003
- Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodiesVaccine, 2002
- Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccineVaccine, 2000